hTEPs (human tissue engineered products) change of sovereignty at the EC: a taste of things to come?
This article was originally published in Clinica
Executive Summary
The transfer of the file on human tissue engineered products into the pharmaceutical unit of the European Commission, just as a first draft Regulation was about to appear, is not only frustrating for industry but also raises serious questions about the manner in which the decision was made, writes Amanda Maxwell.